GSR Appoints Jon Loflin as Chief Risk Officer
Article by admin
Previous Story
Braintrace Named in 2021 Gartner ‘Emerging Technologies: Adoption Growth Insights for Network Detection and Response’ Report
Next Story
IMBRUVICA® (ibrutinib)-Based Combination Regimen as a Fixed-Duration, First-Line Treatment for Chronic Lymphocytic Leukaemia Demonstrates High Rates of Disease Control
Related Articles
Conceal and TerraOne (member of Zero One Group) Announce Strategic Partnership to Enhance Cybersecurity Solutions
Conceal and TerraOne (member of Zero One Group) Announce Strategic...
Fraudulent Claims Balloon by 400% in Legal Sector Over Two-Year Span; Sparks Demand for Enhanced Security Solutions
Fraudulent Claims Balloon by 400% in Legal Sector Over Two-Year...